Thrombospondin-1, vascular endothelial growth factor expression and their relationship with p53 status in prostate cancer and benign prostatic hyperplasia

BJU International

Volumn 89, Issue 3, 2002, Pages 303-309

  Kwak, C ^a   Jin, R J ^a   Lee, C ^a   Park, M S ^a   Lee, S E ^a  

^a Seoul National University Hospital   (South Korea)

Author keywords

p53; Prostate cancer; Thrombospondin 1; Vascular endothelial growth factor

Indexed keywords

ANDROGEN; ANGIOGENESIS INHIBITOR; ANGIOGENIC FACTOR; PROTEIN P53; THROMBOSPONDIN 1; VASCULOTROPIN;

ADULT; AGED; ANGIOGENESIS; ARTICLE; CANCER CHEMOTHERAPY; CANCER GRADING; CANCER GROWTH; CANCER STAGING; CARCINOGENESIS; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; METASTASIS; PRIORITY JOURNAL; PROSTATE CARCINOMA; PROSTATE HYPERTROPHY; PROTEIN EXPRESSION; PROTEIN FUNCTION;

ADENOCARCINOMA; AGED; AGED, 80 AND OVER; DISEASE PROGRESSION; ENDOTHELIAL GROWTH FACTORS; HUMANS; IMMUNOHISTOCHEMISTRY; LYMPHOKINES; MALE; MIDDLE AGED; NEOVASCULARIZATION, PATHOLOGIC; PROSTATIC HYPERPLASIA; PROSTATIC NEOPLASMS; THROMBOSPONDIN 1; TUMOR SUPPRESSOR PROTEIN P53; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 0036178598     PISSN: 14644096     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1464-4096.2001.01417.x     Document Type: Article

References (24)

1. Angiogenesis
2. Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis
3. Predictors of pathologic stage in prostatic carcinoma: The role of neovascularity
4. Comparison of microscopic vascularity in benign and malignant prostate tissue
5. Topography of neovascularity in human prostate carcinoma
6. Thrombospondin as a mediator of cancer cell adhesion in metastasis
7. The functions of thrombospondin and its involvement in physiology and pathophysiology
8. Expression of the extracellular matrix molecule thrombospondin inversely correlates with malignant progression in melanoma, lung and breast carcinoma cell lines
9. Transfecfion of thrombospondin 1 complementary DNA into a human breast carcinoma cell line reduces primary tumor growth, metastatic potential, and angiogenesis
10. A human fibrosarcoma inhibits systemic angiogenesis and the growth of experimental metastases via thrombospondin-1
11. Molecular mediators of angiogenesis in bladder cancer
12. Control of angiogenesis in fibroblasts by p53 regulation of thrombospondin-1
13. Thrombospondin-1 expression in bladder cancer, association with p53 alterations, tumor angiogenesis, and tumor progression
14. Mutant p53 potentiates protein kinase C induction of vascular endothelial growth factor expression
15. Wild-type p53 and v-Src exert opposing influences on human vascular endothelial growth factor gene expression
16. Immunohistochemical detection of thrombospondin-1 in formalin-fixed, paraffin-embedded tissue
17. Regulation of tumor growth and metastasis by thrombospondin-1
18. Tumor suppression in human skin carcinoma cells by chromosome 15 transfer or thrombospondin-1 overexpression through halted tumor vascularization
19. Light microscopic immunolocation of thrombospondin in human tissues
20. Vascular endothelial growth factor (VEGF) expression in human prostate cancer. In situ and in vitro expression of VEGF by human prostate cancer cells
21. Vascular permeability factor (vascular endothelial growth factor) is strongly expressed in the normal male genital tract and is present in substantial quantities in semen
22. Vascular endothelial growth factor (VEGF) expression in prostate cancer and benign prostatic hyperplasia
23. Small subgroup of aggressive, highly proliferative prostatic carcinomas defined by p53 accumulation
24. p53 is mutated in a subset of advanced-stage prostate cancers